Evidence map›Paper›PMID 41771757›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Modeling Polymeric Drug Release: The Emerging Role of Machine Learning.

Ryan N Woodring, Kristy M Ainslie

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Modeling Polymeric Drug Release: The Emerging Role of Machine Learning.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ryan N WoodringDivision of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, North Carolina, USA.
Kristy M AinslieDivision of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-1820-8382

Funding

Tunable Temporal Drug Release for Optimized Synergistic Combination Therapy of GlioblastomaR01CA257009 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AINSLIE, KRISTY M · 2021 to 2025
$1.7M
NCI NIH HHS R01 CA257009NIH HHS R01CA257009Pharmalliance Research Clusters for Doctoral Training (PARCDT) sponsorship for graduate research
6 · The paper itself

Abstract

Polymeric drug formulations have significantly improved the safety, efficacy, and clinical impact of many therapies. A persistent challenge for formulation scientists, however, lies in accurately characterizing time-dependent drug release. For decades, researchers have relied on mathematical and physical principles, with a focus on transport phenomena, to interpret release kinetics from various polymeric systems using mechanistic and empirical models. While these models provide a foundational understanding through equations relating diffusion, swelling, and erosion, they often depend on simplifying assumptions and are often limited to a retrospective analysis of in vitro data. Recent advances in artificial intelligence (AI) have since opened the door for a new frontier in modeling strategies. Specifically, machine learning (ML) is being used not only to characterize drug release but also predict it while unveiling key formulation parameters governing unique kinetic profiles. This approach can support faster and more efficient development of polymeric systems. In this review, we explore how traditional drug release models have set the stage for ML in drug delivery research. We discuss important trends across recent ML applications, including data compilation, processing, architecture selection, and performance metrics. This perspective aims to provide scientists with a practical roadmap of ML applications used in formulation development. By integrating these tools with established knowledge, researchers can advance the design and translation of the next generation of polymer-based drug delivery systems. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies.

Indexed as

Drug LiberationMachine LearningPolymersDrug Delivery SystemsHumansPredictive Learning ModelsPolymers

Identifiers

PMID41771757
PMCPMC12953059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.